Concurrent therapy with immune checkpoint inhibitors and TNF α blockade in patients with gastrointestinal immune-related adverse events

ConclusionsConcurrent treatment with anti-TNF α and ICI appears to be safe, facilitates steroid tapering, and prevents irEC. Prospective clinical trials are needed to assess the outcomes of this treatment modality.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research